Study of RVT-501 in Adult and Adolescent Subjects With Atopic Dermatitis
Phase of Trial: Phase II
Latest Information Update: 28 Jul 2017
At a glance
- Drugs RVT 501 (Primary)
- Indications Atopic dermatitis
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Dermavant Sciences
- 25 Jul 2017 Status changed from active, no longer recruiting to completed.
- 06 Jun 2017 Status changed from recruiting to active, no longer recruiting.
- 21 Dec 2016 Status changed from not yet recruiting to recruiting, according to a Dermavant Sciences media release.